NovoStitch Pro Meniscal Repair System receives FDA 510(k) clearance: 4 insights

Ceterix Orthopaedics’ NovoStitch Pro Meniscal Repair System earned FDA 510(k) clearance.

Advertisement

Here are four things to know.

1. Ceterix’s NovoStitch systems are designed to allow surgeons to arthroscopically place stitches in tight joint compartments, addressing complex meniscal tears.

2. The new NovoStitch Pro includes an updated handle design, well-defined visual cues for stitch placement accuracy and upper jaw texturing for improved stability and control.

3. The NovoStitch Pro Meniscal Repair System is indicated for approximation of soft tissue in meniscal repair procedures. The new system is designed to enable surgeons to place suture patterns that were previously impossible or possible only in open procedures.

4. Meniscus surgery is the most common arthroscopic procedure in the U.S., with approximately 1 million performed annually.

More articles on devices:

Safe Orthopaedics sells 10k surgical kits: 4 highlights

OrthoPediatrics earns Best Places to Work award: 4 takeaways

Mazor Robotics experiences continued growth: 3 key points

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new product launches and leadership appointments, here are seven key headlines from Stryker in the first quarter of 2026.…

  • Xtant Medical’s 2025 revenue reached $133.9 million, a 14% increase year over year, according to financial results posted March 31.…

Advertisement

Comments are closed.